Catalio closes fund after an evolution of strategy and target

The firm's first special situations strategy focused on biotech companies raises $85m.

10 November 2022•2 mins read
Wellcome Trust medical research endowment DNA
LinkedInXEmail
LinkedInXEmail

Related articles